{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:06:00Z","timestamp":1791165960227,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Photodiagnosis and Photodynamic Therapy"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.pdpdt.2021.102325","type":"journal-article","created":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T18:05:54Z","timestamp":1621101954000},"page":"102325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Sequential treatment with calcitriol and methyl aminolevulinate-daylight photodynamic therapy for patients with multiple actinic keratoses of the upper extremities"],"prefix":"10.1016","volume":"34","author":[{"given":"Stefano","family":"Piaserico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Piccioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlota","family":"Guti\u00e9rrez Garc\u00eca-Rodrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Sacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Concetta","family":"Fargnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.pdpdt.2021.102325_bib0005","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2133.2007.08267.x","article-title":"Pathology and pathobiology of actinic (solar) keratosis- an update","volume":"157","author":"Roewert-Huber","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.pdpdt.2021.102325_bib0010","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/jdv.12848","article-title":"Actinic keratosis with atypical basal cells (AK I) is the most common lesion associated with invasive squamous cell carcinoma of the skin","volume":"29","author":"Fern\u00e1ndez-Figueras","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.pdpdt.2021.102325_bib0015","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/jdv.13626","article-title":"Actinic keratosis: correlation between clinical and histological classification systems","volume":"30","author":"Schmitz","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"1_suppl","key":"10.1016\/j.pdpdt.2021.102325_bib0020","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1177\/1203475417702994","article-title":"Structured expert consensus on actinic keratosis: treatment algorithm focusing on daylight PDT","volume":"21","author":"Calzavara-Pinton","year":"2017","journal-title":"J. Cutan. Med. Surg."},{"key":"10.1016\/j.pdpdt.2021.102325_bib0025","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1111\/jdv.16017","article-title":"European Dermatology Forum guidelines on topical photodynamic therapy 2019Part 1: treatment delivery and established indications - actinic keratoses, Bowen\u2019s disease and basal cell carcinomas","volume":"33","author":"Morton","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.pdpdt.2021.102325_bib0030","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1684\/ejd.2016.2882","article-title":"Long-term efficacy and safety of daylight photodynamic therapy with methyl amninolevulinate for actinic keratosis of the face and scalp","volume":"27","author":"Fargnoli","year":"2017","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.pdpdt.2021.102325_bib0035","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/jdv.14691","article-title":"Patient and physician satisfaction in an observational study with methyl aminolevulinate daylight photodynamic therapy in the treatment of multiple actinic keratoses of the face and scalp in six European countries","volume":"32","author":"Fargnoli","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.pdpdt.2021.102325_bib0040","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/j.1365-2133.2008.08488.x","article-title":"Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities","volume":"158","author":"Kaufmann","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.pdpdt.2021.102325_bib0045","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1468-3083.2009.03259.x","article-title":"Intraindividual, right-left comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities","volume":"23","author":"Sotiriou","year":"2009","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.pdpdt.2021.102325_bib0050","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000246376","article-title":"Photodynamic therapy with topical application of 5-aminolevulinic acid in the treatment of actinic keratoses: an initial clinical study","volume":"192","author":"Szeimies","year":"1996","journal-title":"Dermatology"},{"issue":"3 Pt 1","key":"10.1016\/j.pdpdt.2021.102325_bib0055","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0190-9622(99)70114-3","article-title":"A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses","volume":"41","author":"Kurwa","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.pdpdt.2021.102325_bib0060","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/j.1365-2133.2011.10265.x","article-title":"Comparison of protoporphyrin IX accumulation and destruction during methylaminolevulinate photodynamic therapy of skin tumours located at acral and nonacral sites","volume":"164","author":"Tyrrell","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.pdpdt.2021.102325_bib0065","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/jdv.15459","article-title":"Efficacy of photodynamic therapy combined with topical interventions for the treatment of actinic keratosis: a meta-analysis","volume":"33","author":"Heppt","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.pdpdt.2021.102325_bib0070","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1080\/00015550510032887","article-title":"A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp","volume":"85","author":"Tarstedt","year":"2005","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.pdpdt.2021.102325_bib0075","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.pdpdt.2019.05.031","article-title":"Single versus two-treatment schedule of methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient randomized trial","volume":"27","author":"Guti\u00e9rrez Garc\u00eda-Rodrigo","year":"2019","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2021.102325_bib0080","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jaad.2008.12.032","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies","volume":"60","author":"Menter","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.pdpdt.2021.102325_bib0085","doi-asserted-by":"crossref","first-page":"6040","DOI":"10.1158\/0008-5472.CAN-11-0805","article-title":"Vitamin D3 enhances the apoptotic response of epithelial tumors to aminolevulinate-based photodynamic therapy","volume":"71","author":"Anand","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.pdpdt.2021.102325_bib0090","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1172\/JCI89820","article-title":"Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy","volume":"127","author":"Cunningham","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pdpdt.2021.102325_bib0095","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.pdpdt.2017.11.019","article-title":"Calcipotriol as pretreatment prior to daylight-mediated photodynamic therapy in patients with actinic keratosis: a case series","volume":"21","author":"Galimberti","year":"2018","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2021.102325_bib0100","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/bjd.16473","article-title":"A randomized split-scalp study comparing calcipotriol-assisted methyl aminolaevulinate photodynamic therapy (MAL-PDT) with conventional MAL-PDT for the treatment of actinic keratosis","volume":"179","author":"Torezan","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.pdpdt.2021.102325_bib0105","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jaad.2017.11.027","article-title":"Topical calcipotriol before ablative fractional laser-assisted photodynamic therapy enhances treatment outcomes for actinic keratosis in Fitzpatrick grades III-V skin: a prospective randomized clinical trial","volume":"78","author":"Seo","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.pdpdt.2021.102325_bib0110","doi-asserted-by":"crossref","first-page":"101803","DOI":"10.1016\/j.pdpdt.2020.101803","article-title":"Topical tacalcitol as neoadjuvant for photodynamic therapy of acral actinic keratoses: an intra-patient randomized study","volume":"31","author":"Borgia","year":"2020","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2021.102325_bib0115","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3390\/jcm9020398","article-title":"Influence of serum vitamin D level in the response of actinic keratosis to photodynamic therapy with methylaminolevulinate","volume":"9","author":"Moreno","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.pdpdt.2021.102325_bib0120","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2340\/00015555-2612","article-title":"Pretreatment with 5-fluorouracil cream enhances the efficacy of daylight-mediated photodynamic therapy for actinic keratosis","volume":"97","author":"Nissen","year":"2017","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.pdpdt.2021.102325_bib0125","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1038\/bjc.1998.292","article-title":"Differentiation-specific increase in ALA-induced protoporphyrin IX accumulation in primary mouse keratinocytes","volume":"77","author":"Ortel","year":"1998","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.pdpdt.2021.102325_bib0130","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.pdpdt.2014.05.001","article-title":"Improve efficacy of topical ALA-PDT by calcipotriol through up-regulation of coproporphyrinogen oxidase","volume":"11","author":"Yang","year":"2014","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2021.102325_bib0135","article-title":"Topical calcitriol prior to photodynamic therapy enhances treatment efficacy in non-melanoma skin cancer mouse models","volume":"9308","author":"Rollakanti","year":"2015","journal-title":"Proc. SPIE. Int. Soc. Opt. Eng."},{"key":"10.1016\/j.pdpdt.2021.102325_bib0140","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/phpp.12150","article-title":"Calcipotriol pretreatment enhances methyl aminolevulinate-induced protoporphyrin IX: an in vivo study in hairless mice","volume":"31","author":"Bay","year":"2015","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"10.1016\/j.pdpdt.2021.102325_bib0145","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ccr.2012.08.017","article-title":"Elevated epidermal thymic stromal lymphopoietin levels establish an antitumor environment in the skin","volume":"22","author":"Demehri","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pdpdt.2021.102325_bib0150","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ccr.2012.08.016","article-title":"Loss of cutaneous TSLP-dependent immune responses skews the balance of inflammation from tumor protective to tumor promoting","volume":"22","author":"Di Piazza","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pdpdt.2021.102325_bib0155","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/php.13230","article-title":"Vitamin d and other differentiation-promoting agents as neoadjuvants for photodynamic therapy of cancer","volume":"96","author":"Maytin","year":"2020","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.pdpdt.2021.102325_bib0160","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jsbmb.2004.03.072","article-title":"1,25-Dihydroxyvitamin D and three low-calcemic analogs decrease UV-induced DNA damage via the rapid response pathway","volume":"89\u201390","author":"Wong","year":"2004","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.pdpdt.2021.102325_bib0165","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1365-2133.2003.05228.x","article-title":"Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3 microg g(\u22121) ointment and calcipotriol 50 microg g(\u22121) ointment on chronic plaque psoriasis localized in facial, hairline, retroauricular or flexural areas","volume":"148","author":"Ortonne","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.pdpdt.2021.102325_bib0170","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1468-3083.2006.01913.x","article-title":"An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg\/g ointment vs. calcipotriol 50 microg\/g ointment in subjects with mild to moderate chronic plaque-type psoriasis","volume":"21","author":"Zhu","year":"2007","journal-title":"J. Eur. Acad. Dermatol. Venereol."}],"container-title":["Photodiagnosis and Photodynamic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100021001514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100021001514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:42:40Z","timestamp":1761612160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1572100021001514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":34,"alternative-id":["S1572100021001514"],"URL":"https:\/\/doi.org\/10.1016\/j.pdpdt.2021.102325","relation":{},"ISSN":["1572-1000"],"issn-type":[{"value":"1572-1000","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sequential treatment with calcitriol and methyl aminolevulinate-daylight photodynamic therapy for patients with multiple actinic keratoses of the upper extremities","name":"articletitle","label":"Article Title"},{"value":"Photodiagnosis and Photodynamic Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pdpdt.2021.102325","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102325"}}